Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.38 - $0.89 $17,278 - $40,469
45,471 New
45,471 $37,000
Q1 2021

May 17, 2021

SELL
$1.3 - $3.24 $26,000 - $64,800
-20,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$1.01 - $1.77 $20,200 - $35,400
20,000 New
20,000 $27,000

Others Institutions Holding SESN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About Sesen Bio, Inc.


  • Ticker SESN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,702,000
  • Market Cap $127M
  • Description
  • Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...
More about SESN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.